Wegovy (semaglutide) has been proven to help people lose up to 21% of their starting body weight at the maximummaintenance dose of 7.2mg for 72 weeks
While semaglutide is usually safe, there can be serious risks like pancreatitis, thyroid tumors, including medullary thyroid carcinoma, and issues with your kidneys, including acute kidney injury
What evidence is needed to strengthen my lawsuit against Trulicity
External resources PubMed: Administration errors of compounded semaglutide reported to a poison control center Scientific American: People are overdosing on semaglutide drugs For researchers serious about getting their semaglutide dosing right the first time and every time after, SeekPeptides offers the most comprehensive resource available: concentration-specific calculators, protocol tracking tools, expert-verified conversion charts, and a community of thousands who have navigated these exact dosing questions
If you are using Wegovy and have questions, talk with your doctor or pharmacist